| 000 | 01923cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030228.0 | ||
| 008 | 100516s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.09.M.Sc.2010.Wa.P | ||
| 100 | 0 | _aWalaa Hamido Elsayed Ahmed Elmaadawy | |
| 245 | 1 | 0 |
_aPossible protective effects of losartan and silymarin on liver fibrosis in murine schistosoma mansoni / _cWalaa Hamido Elsayed Ahmed Elmaadawy ; Supervised Afaf A. Ain Shoka , Fatma Abdellatif Ebeid |
| 246 | 1 | 5 | _aالتأثيرات الواقية المحتملة لعقار لوسارتان وسليمارين على التليف الكبدى فى البلهارسيا المعوية التجريبية |
| 260 |
_aCairo : _bWalaa Hamido Elsayed Ahmed Elmaadawy , _c2010 |
||
| 300 |
_a205P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology | ||
| 520 | _aSchistosomiasis as one of the fibrotic hepatic diseases remains one of the world's most important human helminth infections in terms of morbidity and mortality . Several studies have demonstrated that renin - angiotensin receptor blockers or silymarin could reduce experimental liver fibrosis . The present study was designed to investigate the potential antifbrotic effects of losartan or silymarin in combination with PZQ in an experimental model of liver fibrosis induced by S. mansoni infection | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aLiver fibrosis | |
| 653 | 4 | _aPraziquantel | |
| 653 | 4 | _aS. mansoni | |
| 700 | 0 |
_aAfaf A. Ain Shoka , _eSupervisor |
|
| 700 | 0 |
_aFatma Abdellatif Ebeid , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aMustafa _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c30311 _d30311 |
||